Gene DX INC:1108521 [24-002891] gene DX quote: ZM245 gene DX invoice# Q041924ZM245

Ended Purchase Order Awarded Last action

Contract number
75N92E24P00139
Awardee
Awarding agency
Obligated
$25,000

Award facts

Contract value 100% obligated
$25,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
MONTGOMRY VLG, MD 20877, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute to Genedx, LLC, a subsidiary of Opko Health, Inc. The $25,000.00 firm fixed-price purchase order is for the provision of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing. The contract has a completion date of June 30, 2025. Genedx is the prime contractor and there are no reported subcontractors. This contract award is not associated with a larger indefinite delivery vehicle, and it does not have a set-aside designation.

Quick answers

Who was awarded contract 75N92E24P00139?

75N92E24P00139 was awarded to Genedx, LLC by National Human Genome Research Institute (National Institutes of Health) on June 1, 2024.

How much is contract 75N92E24P00139 worth?

The government has obligated $25,000 on 75N92E24P00139.

Was contract 75N92E24P00139 competed?

The extent of competition for 75N92E24P00139 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award